as of 2026-10-27
Report date
Oct 27, 2026
Web data generated
2026-10-27 1:47 PM PDT
Alpha report generated
2026-10-27 1:46 PM PDT
Alpha web build revision b2369513cc04Alpha web package 20261027T204824521773Z-cc7091ae59c8

NBIX

Neurocrine Biosciences

NBIX

HealthcareBiotechnology$14.8B market cap
Meridian score93Rank #50 of 701as of Oct 27Strong
ResearchNot researched
QualityQuality: 72nd percentile
MomentumMomentum: 69th percentile
GrowthGrowth: 86th percentile
ValuationValuation: 63rd percentile
ExpectationsExpectations: 95th percentile

Evidence to review

  • Financial comparability: Goodwill and intangible assets increased materially; review acquisition effects.
Price and trend
Price$146.00
1M+4.0%
3M-19.2%
6M+14.0%
52w position37.3%
From high-21.6%
Relative volume0.8x
As ofOct 27, 2026
Above 21d: yesAbove 50d: noAbove 200d: no50d over 200d: no
Back to the Meridian rank